Recent recalls by Philips have highlighted the importance of product liability and patient safety in the healthcare sector. The latest recall involves approximately 57,000 Evo ventilators due to issues with the machines’ air flow sensors.
Philips’ Respironics unit has faced a series of recalls since 2021, initially related to soundproofing foam used in its sleep apnea devices and ventilators. The Evo ventilator, designed for hospital and professional care settings, is now undergoing its second Class I recall in recent months. The recent recall, labeled as Class I by the U.S. Food and Drug Administration (FDA), highlights the severity of the issue.